Center for Cancer & Blood Disorders

Bethesda, Maryland 20817

0 studies enrolling now · 14 studies all time

What they study most

Breast Cancer, Cachexia, Chronic Idiopathic Thrombocytopenic Purpura, Chronic Lymphocytic Leukemia, Esophagitis, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Multiple Myeloma, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Carcinoma, Non-small Cell Lung Carcinoma, Pneumonitis

Studies at this site

• DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate — Completed
• Oprozomib and Dexamethasone,in Combination With Lenalidomide or Oral Cyclophosphamide to Treat Newly Diagnosed Multiple Myeloma — Stopped early
• Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants — Completed
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer — Completed
• Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer — Completed
• Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer — Completed
• Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. — Completed
• A Study to Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed
• Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer — Completed
• Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients — Completed
• Xcellerated T CellsTM in Patients With Multiple Myeloma — Completed
• Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients — Status unconfirmed